Should Patients With NAFLD/NASH Be Surveyed for HCC?

REIG, Maria et al. Should Patients With NAFLD/NASH Be Surveyed for HCC? In: Transplantation, 2019, vol. 103, n° 1, p. 39–44. doi: 10.1097/TP.0000000000002361

Article (Published version)

Identifiers

PID : unige:114608
DOI : 10.1097/TP.0000000000002361
PMID : 30080818

Additional URL for this publicationhttps://journals.lww.com/transplantjournal/Fulltext/2019/01000/Should_Patients_With_NAFLD_NASH_Be_Surveyed_for.13.aspx

Journal ISSN0041-1337

1108views

1downloads

Creation18/02/2019 10:42:00

First validation18/02/2019 10:42:00

Update time20/01/2025 07:28:17

Status update20/01/2025 07:28:17

Last indexation20/01/2025 07:32:55

Archive ouverte UNIGE

Should Patients With NAFLD/NASH Be Surveyed for HCC?

Patients with nonalcoholic fatty liver disease (NAFLD) are at risk of developing hepatocellular carcinoma (HCC), but the magnitude of the association still needs to be determined to define the need for a specific surveillance strategy.

Technical informations